Joshua K. Tay

1.4k total citations
36 papers, 750 citations indexed

About

Joshua K. Tay is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Joshua K. Tay has authored 36 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 9 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Joshua K. Tay's work include Viral-associated cancers and disorders (11 papers), Head and Neck Cancer Studies (7 papers) and Respiratory viral infections research (6 papers). Joshua K. Tay is often cited by papers focused on Viral-associated cancers and disorders (11 papers), Head and Neck Cancer Studies (7 papers) and Respiratory viral infections research (6 papers). Joshua K. Tay collaborates with scholars based in Singapore, United States and Australia. Joshua K. Tay's co-authors include Woei Shyang Loh, Kwok Seng Loh, Chwee Ming Lim, John B. Sunwoo, June Ho Shin, De Yun Wang, Vernon J. Lee, Andrew J. Gentles, Olivier Gevaert and Jonathan Yap and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and The Journal of Immunology.

In The Last Decade

Joshua K. Tay

33 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joshua K. Tay Singapore 14 212 192 191 178 95 36 750
Felipe Andreo Spain 17 69 0.3× 115 0.6× 637 3.3× 346 1.9× 72 0.8× 61 1.1k
Craig Brown Canada 16 152 0.7× 51 0.3× 49 0.3× 173 1.0× 60 0.6× 33 592
Jean-Paul Chigot France 19 96 0.5× 194 1.0× 136 0.7× 139 0.8× 53 0.6× 50 1.2k
Yunxia Tang China 10 120 0.6× 76 0.4× 115 0.6× 139 0.8× 615 6.5× 30 890
Guiju Gao China 12 96 0.5× 91 0.5× 80 0.4× 200 1.1× 770 8.1× 40 1.0k
Faézeh Legrand France 19 133 0.6× 229 1.2× 64 0.3× 521 2.9× 543 5.7× 56 1.2k
Kym Pham Australia 9 458 2.2× 189 1.0× 320 1.7× 321 1.8× 83 0.9× 11 1.1k
Shilpi Gupta India 12 229 1.1× 194 1.0× 57 0.3× 238 1.3× 63 0.7× 38 773
Mingxia Zhang China 16 190 0.9× 53 0.3× 72 0.4× 266 1.5× 616 6.5× 54 1.1k
Yingshuo Wang China 13 92 0.4× 22 0.1× 179 0.9× 190 1.1× 66 0.7× 53 608

Countries citing papers authored by Joshua K. Tay

Since Specialization
Citations

This map shows the geographic impact of Joshua K. Tay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua K. Tay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua K. Tay more than expected).

Fields of papers citing papers by Joshua K. Tay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua K. Tay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua K. Tay. The network helps show where Joshua K. Tay may publish in the future.

Co-authorship network of co-authors of Joshua K. Tay

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua K. Tay. A scholar is included among the top collaborators of Joshua K. Tay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua K. Tay. Joshua K. Tay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tay, Joshua K., et al.. (2025). ACE2 and TMPRSS2 gene expression is reduced acutely in SARS-CoV-2 patients but returns to normal with recovery. Scientific Reports. 15(1). 12828–12828. 3 indexed citations
2.
Ong, Enya H.W., Xin Zhang, Joseph Wee, et al.. (2025). Plasma Epstein-Barr virus DNA for disease surveillance in endemic nasopharyngeal carcinoma: Analysis of a real-world database. European Journal of Cancer. 220. 115396–115396. 3 indexed citations
3.
Loh, Kwok Seng, et al.. (2024). Precision Medicine for Nasopharyngeal Cancer—A Review of Current Prognostic Strategies. Cancers. 16(5). 918–918. 9 indexed citations
4.
Teo, Chong Boon, Y H Chan, Joshua K. Tay, & Crystal Cheong. (2024). 12366 The Association Between Obstructive Sleep Apnea And Bone Health: A Systematic Review And Meta-analysis. Journal of the Endocrine Society. 8(Supplement_1).
5.
Chan, Y H, Chong Boon Teo, Joshua K. Tay, & Crystal Cheong. (2024). The association between obstructive sleep apnea and osteoporosis: A systematic review and meta-analysis. Sleep Medicine Reviews. 78. 102006–102006. 1 indexed citations
6.
Shen, Haosheng, Changyu Zhang, Yuanmei Liang, et al.. (2024). Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy. Nature Communications. 15(1). 4343–4343. 32 indexed citations
7.
Cheong, Ian, Eng Eong Ooi, Jianjun Liu, et al.. (2024). Impact of high-risk EBV strains on nasopharyngeal carcinoma gene expression. Oral Oncology. 157. 106941–106941. 2 indexed citations
8.
9.
Chong, Wan Qin, Ross A. Soo, Hsiangling Teo, et al.. (2024). 848MO Phase II open-label randomized study of pembrolizumab with or without bevacizumab in platinum-resistant recurrent/metastatic nasopharyngeal carcinoma (R/M NPC). Annals of Oncology. 35. S614–S614. 1 indexed citations
10.
Ong, Enya H.W., Jingjing Miao, Joseph Wee, et al.. (2023). Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinoma. Oral Oncology. 148. 106655–106655. 10 indexed citations
11.
Tay, Joshua K., et al.. (2023). A Clinicopathology Review and Update of Epstein–Barr Virus-Associated Mesenchymal Tumors. Cancers. 15(23). 5563–5563. 4 indexed citations
12.
Hu, Jianing, et al.. (2022). Deep Learning Fuzzy Inference. American Journal Of Pathology. 192(9). 1295–1304. 2 indexed citations
13.
Chow, James Chung Hang, Anne W.M. Lee, Charlene H. L. Wong, et al.. (2022). Epstein-Barr virus directed screening for nasopharyngeal carcinoma in individuals with positive family history: A systematic review. Oral Oncology. 133. 106031–106031. 4 indexed citations
14.
Wu, Xiaolin, Joshua K. Tay, Cheryl Chan, et al.. (2021). Digital CRISPR-based method for the rapid detection and absolute quantification of nucleic acids. Biomaterials. 274. 120876–120876. 87 indexed citations
15.
Tay, Joshua K., et al.. (2019). A comparison of EBV serology and serum cell‐free DNA as screening tools for nasopharyngeal cancer: Results of the Singapore NPC screening cohort. International Journal of Cancer. 146(10). 2923–2931. 22 indexed citations
16.
Schoppy, David W., et al.. (2018). Assessing the Impact of Targeting CEACAM1 in Head and Neck Squamous Cell Carcinoma. Otolaryngology. 159(1). 76–84. 14 indexed citations
17.
Brennan, Kevin, June Ho Shin, Joshua K. Tay, et al.. (2017). NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma. Scientific Reports. 7(1). 17064–17064. 73 indexed citations
18.
Tay, Joshua K., Min En Nga, & Kwok Seng Loh. (2013). Pilomatricoma of the cheek: A benign tumor mimicking metastatic squamous cell carcinoma on FDG PET/CT. American Journal of Otolaryngology. 35(3). 452–455. 7 indexed citations
19.
Lee, Vernon J., Jonathan Yap, Alex R. Cook, et al.. (2010). Effectiveness of Public Health Measures in Mitigating Pandemic Influenza Spread: A Prospective Sero‐Epidemiological Cohort Study. The Journal of Infectious Diseases. 202(9). 1319–1326. 40 indexed citations
20.
Tay, Joshua K., Chay Hoon Tan, Siow‐Ann Chong, & Ene‐Choo Tan. (2007). Functional polymorphisms of the cytochrome P450 1A2 (CYP1A2) gene and prolonged QTc interval in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(6). 1297–1302. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026